Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.

Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.

A single-nucleotide polymorphism (SNP) in exon 4 results in expression of either arginine (72R) or proline (72P) at codon 72 of p53. We demonstrate that the in vitro response of cells exposed to anticancer agents is strongly influenced by this SNP in wild-type p53. In inducible systems and in cells...

Full description

Bibliographic Details
Main Authors:	Sullivan, A, Syed, N, Gasco, M, Bergamaschi, D, Trigiante, G, Attard, M, Hiller, L, Farrell, P, Smith, P, Lu, X, Crook, T
Format:	Journal article
Language:	English
Published:	2004

Similar Items

p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.
by: Bergamaschi, D, et al.
Published: (2003)

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.
by: Bergamaschi, D, et al.
Published: (2006)

ASPP proteins specifically stimulate the apoptotic function of p53.
by: Samuels-Lev, Y, et al.
Published: (2001)

iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
by: Bergamaschi, D, et al.
Published: (2003)

The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP.
by: Mantovani, F, et al.
Published: (2007)

ASPP1 and ASPP2: common activators of p53 family members.
by: Bergamaschi, D, et al.
Published: (2004)

A p53-derived apoptotic peptide derepresses p73 to cause tumor regression in vivo.
by: Bell, H, et al.
Published: (2007)

Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
by: Bergamaschi, D, et al.
Published: (2005)

The Role of GDF15 in Regulating the Canonical Pathways of the Tumor Microenvironment in Wild-Type p53 Ovarian Tumor and Its Response to Chemotherapy
by: Daisy I. Izaguirre, et al.
Published: (2020-10-01)

Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo
by: Zhao X, et al.
Published: (2019-02-01)

Functional Diversity of p53 in Human and Wild Animals
by: Yi Li, et al.
Published: (2019-03-01)

Thermodynamic stability of wild-type and mutant p53 core domain.
by: Bullock, A, et al.
Published: (1997)

Photodynamic antimicrobial chemotherapy for Staphylococcus aureus and multidrug-resistant bacterial burn infection in vitro and in vivo
by: Mai B, et al.
Published: (2017-08-01)

In Vitro Assessment of the Role of p53 on Chemotherapy Treatments in Neuroblastoma Cell Lines
by: Idoia Blanco-Luquin, et al.
Published: (2021-11-01)

A new strategy to resume the apoptosis activity of p53 in leukemia cell lines retaining wild-type p53.
by: Liu, Z, et al.
Published: (2007)

A new strategy to resume the apoptosis activity of p53 in leukemia cell lines retaining wild-type p53
by: Liu, Z, et al.
Published: (2007)

Resistance to in vivo and in vitro chemotherapies in the brazilian Amazonia
by: Maria das Graças Alecrim
Published: (1986-01-01)

CRISPR screens are feasible in TP53 wild‐type cells
by: Kevin R Brown, et al.
Published: (2019-08-01)

Genomic Characterization of TP53–Wild-Type Esophageal Carcinoma
by: Alexander Quaas, et al.
Published: (2019-01-01)

Role of TP53 polymorphisms in sub-Saharan mucosal cancers
by: Buonaguro Luigi, et al.
Published: (2010-10-01)

Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
by: Jin-Ah Kim, et al.
Published: (2023-09-01)

Small-Molecule Reactivation of Mutant p53 to Wild-Type-like p53 through the p53-Hsp40 Regulatory Axis
by: Hiraki, Masatsugu, et al.
Published: (2017)

Triangular Relationship between p53, Autophagy, and Chemotherapy Resistance
by: Jingwen Xu, et al.
Published: (2020-11-01)

Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo
by: Slee, EA, et al.
Published: (2010)

p53 Codon 72 Polymorphism and Risk of Cervical Cancer
by: JOSÉ M OJEDA, et al.
Published: (2003-01-01)

Single-nucleotide polymorphisms in the p53 signaling pathway.
by: Grochola, L, et al.
Published: (2010)

Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53
by: Phong Lu, et al.
Published: (2019-05-01)

In the right place at the right time: analysis of p53 serine 312 phosphorylation in vivo
by: Slee, EA, et al.
Published: (2011)

High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assays.
by: Roland Houben, et al.
Published: (2011-01-01)

Signaling from p53 to NF-κB Determines the Chemotherapy Responsiveness of Neuroblastoma
by: Michael B. Armstrong, et al.
Published: (2006-11-01)

The HDAC Inhibitor Panobinostat Promotes Expression of Delta 133p53 Variants in TP53 Wild-type Bladder Cancer Cells
by: Groselj, B, et al.
Published: (2012)

SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma
by: Sara Gomes, et al.
Published: (2019-08-01)

Functional regulation of p73 and p63: development and cancer.
by: Melino, G, et al.
Published: (2003)

Reply to “CRISPR screens are feasible in TP53 wild‐type cells”
by: Emma Haapaniemi, et al.
Published: (2019-08-01)

Editorial: Advances in wild type and mutant p53 research in cancer
by: Olga N. Hernández-de la Cruz, et al.
Published: (2022-11-01)

TP53 codon 72 Polymorphism and P53 Protein Expression in Colorectal Cancer Specimens in Isfahan
by: Mehdi Nikbahkt Dastjerdi
Published: (2011-02-01)

TP53 Codon 72 Polymorphism and P53 Protein Expression in Colorectal Cancer Specimens in Isfahan
by: Mehdi Nikbahkt Dastjerdi
Published: (2011-02-01)

The Stapled Peptide PM2 Stabilizes p53 Levels and Radiosensitizes Wild-Type p53 Cancer Cells
by: Anja Charlotte Lundgren Mortensen, et al.
Published: (2019-09-01)

p53 Amino-terminus region (1-125) stabilizes and restores heat denatured p53 wild phenotype.
by: Anuj Kumar Sharma, et al.
Published: (2009-10-01)

2-[(4-Hydroxybenzyl) Amino] Phenol (HBAP) Restores the Mutated p53 to the Level Similar to That of Wild-Type p53 Protein and Inhibits Breast Cancer Growth in vivo to by Inducing Tumor Cells Apoptosis
by: Chenxi Xu, et al.
Published: (2020-11-01)